Showing results (471-480 of 591) with videos related to

Sort By:
Pageof 60
International Journal of Cancer|March 20, 2009
Cancer/testis antigen CT45: analysis of mRNA and protein expression in human cancerYao-Tseng Chen, Melinda Hsu, Peishan Lee, et al.
Plos One|March 26, 2011
Multiple cancer/testis antigens are preferentially expressed in hormone-receptor negative and high-grade breast cancersYao-Tseng Chen, Dara S Ross, Rita Chiu, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1987
Diagnosis of renal proximal tubular injury by urinary immunoassay for a proximal tubular antigen, the adenosine deaminase binding proteinN E Tolkoff-Rubin, R E Thompson, D J Piper, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 1, 2007
Immunization with a recombinant MAGE-A3 protein after high-dose therapy for myelomaSusann Szmania, Sacha Gnjatic, Guido Tricot, et al.
Electrophoresis|March 1, 1997
Electrophoretic analysis of the novel antigen for the gastrointestinal-specific monoclonal antibody, A33H Ji, R L Moritz, G E Reid, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 2, 1997
Tumor necrosis factor alpha plays a central role in immune-mediated clearance of adenoviral vectorsK B Elkon, C C Liu, J G Gall, et al.
International Journal of Oncology|September 12, 2006
OY-TES-1 expression and serum immunoreactivity in epithelial ovarian cancerJonathan Tammela, Akiko Uenaka, Toshiro Ono, et al.
Cancer Research|October 30, 2003
Antigen-specific immunity in neuroblastoma patients: antibody and T-cell recognition of NY-ESO-1 tumor antigenMonica Rodolfo, Roberto Luksch, Elisabeth Stockert, et al.
Cancer Immunity|October 20, 2007
LUD 00-009: phase 1 study of intensive course immunization with NY-ESO-1 peptides in HLA-A2 positive patients with NY-ESO-1-expressing cancerArmin Bender, Julia Karbach, Antje Neumann, et al.
Cancer Immunity|November 14, 2008
Identification of the HERV-K gag antigen in prostate cancer by SEREX using autologous patient serum and its immunogenicityToshiaki Ishida, Yuichi Obata, Nobuya Ohara, et al.
Pageof 60